News We’re Watching: Medicare Payments For Renal Denervation; Acquisitions for Tempus And Boston Sci; LumiThera And Caris Land FDA Authorizations

 
• By Elizabeth Orr, Marion Webb, and Natasha Barrow

This week, renal denervation systems from Medtronic and Recor won Medicare coverage; Boston Scientific bought cardiac-mapping firm Cortex; Veravas and Phanes Biotech teamed up on an Alzheimer’s diagnostic; and more.

"News We're Watching" Feature Image
• Source: Medtech Insight

More from Medtech Insight

More from Approvals